These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11751791)

  • 21. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
    Jean SS; Hsieh TC; Lee WS; Hsueh PR; Hsu CW; Lam C
    Medicine (Baltimore); 2018 Sep; 97(39):e12278. PubMed ID: 30278498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance.
    Heininger A; Meyer E; Schwab F; Marschal M; Unertl K; Krueger WA
    Intensive Care Med; 2006 Oct; 32(10):1569-76. PubMed ID: 16896852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective decontamination of the digestive tract (SDD): is the game worth the candle?
    van Essen EH; de Jonge E
    Semin Respir Crit Care Med; 2011 Apr; 32(2):236-42. PubMed ID: 21506060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization.
    Hsieh TC; Chen FL; Ou TY; Jean SS; Lee WS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):523-30. PubMed ID: 25442877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
    Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
    BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of selective decontamination of the digestive tract on gastrointestinal enterococcal colonization in ITU patients.
    Humphreys H; Winter R; Pick A
    Intensive Care Med; 1992; 18(8):459-63. PubMed ID: 1289369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A before-after study of multi-resistance and cost of selective decontamination of the digestive tract.
    van der Voort PH; van Roon EN; Kampinga GA; Boerma EC; Gerritsen RT; Egbers PH; Kuiper MA
    Infection; 2004 Oct; 32(5):271-7. PubMed ID: 15624890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective decontamination of the digestive tract in intensive care patients: review and commentary.
    Gomez EC; Markowsky SJ; Rotschafer JC
    Ann Pharmacother; 1992; 26(7-8):963-76. PubMed ID: 1504410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of photodynamic therapy in combination with colistin against a pan-drug resistant Acinetobacter baumannii isolated from burn patient.
    Boluki E; Kazemian H; Peeridogaheh H; Alikhani MY; Shahabi S; Beytollahi L; Ghorbanzadeh R
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():1-5. PubMed ID: 28088439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection.
    Winter R; Humphreys H; Pick A; MacGowan AP; Willatts SM; Speller DC
    J Antimicrob Chemother; 1992 Jul; 30(1):73-87. PubMed ID: 1429339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains.
    Chmielarczyk A; Pilarczyk-Żurek M; Kamińska W; Pobiega M; Romaniszyn D; Ziółkowski G; Wójkowska-Mach J; Bulanda M
    Microb Drug Resist; 2016 Jun; 22(4):328-35. PubMed ID: 26745326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of multi-drug resistant Acinetobacter from an intensive care unit.
    Podnos YD; Cinat ME; Wilson SE; Cooke J; Gornick W; Thrupp LD
    Surg Infect (Larchmt); 2001; 2(4):297-301. PubMed ID: 12593705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience.
    Camus C; Salomon S; Bouchigny C; Gacouin A; Lavoué S; Donnio PY; Javaudin L; Chapplain JM; Uhel F; Le Tulzo Y; Bellissant E
    Crit Care Med; 2014 May; 42(5):1121-30. PubMed ID: 24365857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies.
    Traub WH; Geipel U; Schwarze I; Bauer D
    Chemotherapy; 1999; 45(5):349-59. PubMed ID: 10473923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.